400-920-2911 sales@csnpharm.cn
CAS No.: 1654725-02-6
Synonyms: ABBV-974
GLPG-1837 is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator1, shows enhanced efficacy on CFTR mutants harboring Class III mutations compared to Ivacaftor.
规格 | 价格 | 促销价格 | 库存 | 数量 |
---|
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02325037 | Healthy | Phase 1 | Completed | - | Belgium ... more >> SGS LSS Clinical Pharmacology Unit Antwerp Antwerp, Belgium Collapse << |
NCT02562950 | Healthy | Phase 1 | Completed | - | Belgium ... more >> SGS LSS Clinical Pharmacology Unit Antwerp Antwerp, Belgium Collapse << |
NCT02707562 | Cystic Fibrosis | Phase 2 | Completed | - | Australia ... more >> Royal Adelaide Hospital Adelaide, Australia The Prince Charles Hospital Chermside, Australia Monash Medical Centre Clayton, Australia Sir Charles Gairdner Hospital Nedlands, Australia Mater Adult Hospital South Brisbane, Australia Czech Republic Fakultni nemocnice v Motole Praha 5, Czech Republic Germany Charité Universitätsmedizin Berlin Berlin, Germany Universitätsklinkikum Koeln Cologne, Germany Uniklinik Carl-Gustav-Carus Dresden, Germany Lungenheilkunde München-Pasing München, Germany Ireland Beamont Hospital Dublin, Ireland St. Vincent's University Hospital Dublin, Ireland United Kingdom Queen Elizabeth University Hospital Glasgow, United Kingdom Liverpool Heart and Chest Hospital Liverpool, United Kingdom Royal Brompton Hospital London, United Kingdom The Medicines Evaluation Unit Ltd Manchester, United Kingdom Collapse << |
实验方案
技术信息
CAS号 | 1654725-02-6 | 储存条件 |
|
|||||
分子式 | C16H20N4O3S | 运输 | 蓝冰 | |||||
分子量 | 348.42 | 别名 | ABBV-974 | |||||
溶解度 |
|
动物实验配方 |